Study explores comorbidities' impact on treatment response in juvenile myoclonic epilepsy patients, suggesting significant implications.
To explore the association between psychiatric comorbidities and the number of antiseizure medications (ASMs) in patients with juvenile myoclonic epilepsy (JME), and to evaluate whether these comorbidities increase the likelihood of requiring polytherapy and reduce seizure freedom.
No takes yet. Share an insight, caveat, or question.
Narváez-Labuhn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: